Interferon beta-1a biosimilar (Axxo)

干扰素β-1a生物类似药 (Axxo)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon beta-1a biosimilar (Axxo)
Drug Alias Name干扰素β-1a生物仿制药 (Axxo)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesAxxo
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAxxo
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeL03AB07
Related LinksN/A